Shared Investigator Platform Team at UCSF

Enabling SIP at UCSF is a joint collaboration between the Office of Clinical Trial Activation (OCTA) and the Helen Diller Family Comprehensive Cancer Center (HDFCCC). SIP initiative is part of our synergistic efforts to promote, partner, and ease industry sponsor-based research at UCSF.

The UCSF SIP project team plans to facilitate the on-going adoption and development of SIP at UCSF as a site. SIP Team members will perform the following responsibilities:

• Support UCSF research teams with using SIP
• Administer, configure, and maintain UCSF's as a research site within SIP
• Participate in the ongoing development and adoption of SIP as additional features become available.

Aaron Hudack - OnCore Trainer at OCTA
Emily Nurminen - Associate Director, Clinical Research Program at HDFCCC
Patrick Oh - Associate Director at OCTA
Riya Kishnani - Operations Team Lead at OCTA

Contact us at [email protected] for any inquiries.

Cognizant

Cognizant is the technology vendor that is developing and operating the Shared Investigator Platform on behalf of the industry sponsors participating in SIP.

Industry Sponsors

As of June 2021 the following industry sponsors are using SIP and more may continue to join.

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Lilly, Merck, Pfizer, Roche